Enliven Therapeutics, Inc. (ELVN)

Last Closing Price: 17.77 (2025-05-30)

Receiveable Turnover (Quarterly)

Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable

Enliven Therapeutics, Inc. (ELVN) Receiveable Turnover data is not available.

Figures for fiscal quarter ending 2025-03-31
Income Statement Financials
--
$-28.54M
--
--
$31.69M
$-31.69M
$3.15M
$-28.54M
$-28.54M
$-28.54M
$-28.54M
$-28.54M
$-28.54M
$-31.69M
$-31.66M
50.05M
50.05M
$-0.57
$-0.57
Balance Sheet Financials
$294.32M
$0.40M
$8.25M
$302.57M
$13.97M
--
$0.30M
$14.27M
$288.30M
$288.30M
$288.30M
49.04M
Cash Flow Statement Financials
$-24.13M
$1.43M
$0.23M
$124.17M
$101.70M
$-22.47M
$6.80M
--
--
Fundamental Metrics & Ratios
21.06
--
--
--
--
--
--
--
--
--
--
$-24.15M
--
--
--
--
--
Receiveable Turnover
--
--
-9.90%
-9.90%
-9.43%
-9.90%
$5.88
$-0.48
$-0.48